[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 237,515,856
  • Shares Outstanding, K 540,632
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 11,426 M
  • EBITDA $ 17,793 M
  • 60-Month Beta 0.41
  • Price/Sales 6.38
  • Price/Cash Flow 12.83
  • Price/Book 20.06

Options Overview Details

View History
  • Implied Volatility 30.17% (-0.28%)
  • Historical Volatility 27.97%
  • IV Percentile 73%
  • IV Rank 57.51%
  • IV High 37.59% on 07/28/26
  • IV Low 20.12% on 08/22/25
  • Expected Move (DTE 5) 13.50 (3.07%)
  • Put/Call Vol Ratio 1.34
  • Today's Volume 10,590
  • Volume Avg (30-Day) 12,317
  • Put/Call OI Ratio 1.40
  • Today's Open Interest 140,195
  • Open Int (30-Day) 124,402
  • Expected Range 425.83 to 452.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 35 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $5.69
  • Number of Estimates 9
  • High Estimate $6.04
  • Low Estimate $5.48
  • Prior Year $5.64
  • Growth Rate Est. (year over year) +0.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
359.21 +22.30%
on 07/23/26
443.20 -0.87%
on 08/19/26
+73.09 (+19.96%)
since 07/21/26
3-Month
322.30 +36.31%
on 06/02/26
443.20 -0.87%
on 08/19/26
+101.91 (+30.20%)
since 05/21/26
52-Week
269.77 +62.85%
on 09/26/25
443.20 -0.87%
on 08/19/26
+143.57 (+48.54%)
since 08/21/25

Most Recent Stories

More News
2 Momentum Stocks Worth Investigating and 1 We Avoid

2 Momentum Stocks Worth Investigating and 1 We Avoid

UCB : 35.58 (+0.14%)
TILE : 38.94 (-0.36%)
AMGN : 439.33 (+1.29%)
Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions

Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions

AMGN : 439.33 (+1.29%)
Stock Indices Fall from Early Highs and Settle Mixed

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.83%. September...

AMAT : 492.32 (-0.78%)
B : 47.60 (+2.87%)
ANET : 188.65 (+2.67%)
HL : 20.72 (-0.48%)
CDE : 20.97 (-0.66%)
TXN : 264.36 (-0.47%)
$IUXX : 29,308.86 (+0.33%)
AMGN : 439.33 (+1.29%)
ZNU26 : 108-085s (-0.22%)
SHOP : 149.25 (+1.41%)
COMP : 11.75 (-1.43%)
ESU26 : 7,691.25s (+0.38%)
Why Amgen (AMGN) Stock Is Trading Up Today

Why Amgen (AMGN) Stock Is Trading Up Today

AMGN : 439.33 (+1.29%)
Stocks Supported by Stellar Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. September E-mini S&P futures...

AMAT : 492.32 (-0.78%)
B : 47.60 (+2.87%)
ANET : 188.65 (+2.67%)
HL : 20.72 (-0.48%)
CDE : 20.97 (-0.66%)
WYNN : 100.28 (+0.68%)
TXN : 264.36 (-0.47%)
$IUXX : 29,308.86 (+0.33%)
AMGN : 439.33 (+1.29%)
ZNU26 : 108-085s (-0.22%)
SHOP : 149.25 (+1.41%)
COMP : 11.75 (-1.43%)
Strong Earnings Push the S&P 500 to New Record High

The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. September E-mini S&P futures...

B : 47.60 (+2.87%)
ANET : 188.65 (+2.67%)
HL : 20.72 (-0.48%)
CDE : 20.97 (-0.66%)
WYNN : 100.28 (+0.68%)
$IUXX : 29,308.86 (+0.33%)
AMGN : 439.33 (+1.29%)
ZNU26 : 108-085s (-0.22%)
SHOP : 149.25 (+1.41%)
COMP : 11.75 (-1.43%)
ESU26 : 7,691.25s (+0.38%)
CDW : 137.25 (+2.78%)
AMGN Q2 Deep Dive: Broad Portfolio Powers Guidance Upgrade, Pipeline Progress Remains Focus

AMGN Q2 Deep Dive: Broad Portfolio Powers Guidance Upgrade, Pipeline Progress Remains Focus

AMGN : 439.33 (+1.29%)
Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales

Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales

AMGN : 439.33 (+1.29%)
Amgen: Q2 Earnings Snapshot

Amgen: Q2 Earnings Snapshot

AMGN : 439.33 (+1.29%)
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

THOUSAND OAKS, Calif. , Aug. 4, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2026.

AMGN : 439.33 (+1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 454.56
2nd Resistance Point 447.54
1st Resistance Point 443.43
Last Price 439.33
1st Support Level 432.30
2nd Support Level 425.28
3rd Support Level 421.17

See More

52-Week High 443.20
Last Price 439.33
Fibonacci 61.8% 376.95
Fibonacci 50% 356.48
Fibonacci 38.2% 336.02
52-Week Low 269.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.